Culture independent diagnostic tests (CIDT) for detection of pathogens in clinical specimens have become widely adopted in Australian pathology laboratories. Pathology laboratories are the primary source of notification of pathogens to state and territory surveillance systems. Monitoring and analysis of surveillance data is integral to guiding public health actions to reduce the incidence of disease and respond to outbreaks. As with any change in testing protocol, the advantages and disadvantages of the change from culture based testing to culture independent testing need to be weighed up and the impact on surveillance and outbreak detection assessed. This article discusses the effect of this change in testing on surveillance and public health management of pathogens in Australia, with specific focus on gastrointestinal pathogens.
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What is CIDT and how is it being used in Australia?
A CIDT is any diagnostic test that is performed directly on the clinical specimen without first requiring laboratory culture of a pathogen isolate 1, 2 . Common CIDT methods diagnose an infectious agent by detecting the nucleic acids of the pathogen 
CIDT has revolutionised pathogen detection
Many pathology laboratories have embraced PCR due to the low ongoing cost, speed, and ease of use 1, [4] [5] [6] . PCR requires less training and expertise, and is less subjective than culture, for which experience is required to identify appropriate colonies to select for further characterisation 1, 6 . PCR is generally more sensitive than culture, and can detect pathogens that do not grow easily in culture, have been treated with antibiotics or are in low numbers in the specimen 5, 6 . PCR is more likely to detect a pathogen in specimens with decreased viability due to a delay before testing 7 . PCR can also identify polymicrobial infections whereas culture would likely only detect the fastest growing pathogen 
CIDT must be interpreted with caution
One of the most important uses of surveillance data is for the detection of an increase in disease through comparison with historical data 5, 6 . Therefore, any change in testing method will need to be reviewed in the context of previous results, to enable valid comparison of data from before and after the change in method. Since PCR is more sensitive than traditional culture methods, the detected incidence of pathogens will likely increase after introduction of PCR 5, 7 . However, other factors can also cause an increase in the detected incidence. This can affect the success of interventions or litigation 1, 6 .
The impact of the introduction of PCR is different for each pathogen. For example, Salmonella is easy to grow in culture, so concurrent or reflex culture will result in an isolate for further characterisation most of the time. In contrast, as Campylobacter is fastidious 8 , culture has a much lower sensitivity than PCR, resulting in a higher proportion of specimens positive only by PCR even when culture is attempted.
If the specificity of the primers used in the PCR is not limited to the pathogen in question, the PCR may overestimate incidence of disease. For example, Shigella is genetically closely related to enteroinvasive Escherichia coli (EIEC) 9 and the PCR primers used in commercial multiplex PCRs amplify the ipaH gene, which is common between Shigella and EIEC 10, 11 . Thus, culture-based phenotypic tests are required to differentiate between the two genera. However, Shigella can be difficult to culture 
Conclusion and future
Although it varies for each pathogen, the impact of the introduction of CIDT has both benefits and drawbacks for the laboratory, clinical diagnosis of disease and public health surveillance. It remains important that laboratories continue to perform concurrent or reflex culture in order to inform public health action, especially as WGS becomes more common. This period of extra testing is likely to be transitional, as techniques for sequencing directly from clinical specimens (metagenomics) are developed and neither culture nor PCR will be required for diagnosis of pathogens. In addition to bypassing the requirement for culture, metagenomics will allow detection of previously unknown pathogens via sequencing of all nucleic acid present in a specimen, expanding our knowledge of the agents causing infectious disease.
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